Active, not recruitingPhase 2NCT02861417

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Studying Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Uday R Popat, MD, MD
M.D. Anderson Cancer Center
Intervention
Allogeneic Hematopoietic Stem Cell Transplantation(procedure)
Enrollment
204 enrolled
Eligibility
12-75 years · All sexes
Timeline
20162026

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02861417 on ClinicalTrials.gov

Other trials for Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

Additional recruiting or active studies for the same condition.

See all trials for Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

← Back to all trials